Med Page Today

SEPTEMBER 5, 2024

(MedPage Today) -- Submaximal balloon angioplasty for symptomatic intracranial atherosclerotic stenosis (ICAS) improved outcomes over aggressive medical management alone, the BASIS trial from China showed. The incidence of the composite of any.

Angioplasty 52

Angioplasty Stenosis Outcomes 52

American College of Cardiology

OCTOBER 29, 2024

The routine use of orbital atherectomy did not improve minimal stent area (MSA) or reduce target vessel failure (TVF) at one year compared with conventional balloon angioplasty prior to implantation of a drug-eluting stent (DES) in severely calcified coronary lesions.

Angioplasty 53

Angioplasty Stents Stent Article 53

Frontiers in Cardiovascular Medicine

NOVEMBER 21, 2024

Traditional treatments like plain old balloon angioplasty (POBA) have limited success due to high restenosis rates. Drug-coated balloon angioplasty (DCBA) has emerged as a promising alternative, locally delivering antiproliferative drugs like paclitaxel to reduce restenosis.

Angioplasty 52

Angioplasty Peripheral Arterial Disease Outcomes Research 52

American College of Cardiology

JUNE 6, 2024

The ORBITA-2 (Objective Randomized Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina) trial data demonstrate that, in patients with stable angina and ischemia producing coronary stenoses.

Angina 53

Angina Angioplasty Ischemia Article 53

Journal of Cardiothoracic Surgery

AUGUST 20, 2024

This research evaluates the effect of balloon pulmonary angioplasty (BPA) on cardiac electrophysiological changes in patients with chronic thromboembolic pulmonary hypertension (CTEPH).

Angioplasty 52

Angioplasty Pulmonary Hypertension Electrophysiology 52

American College of Cardiology

OCTOBER 9, 2024

Is balloon angioplasty plus medical management superior to medical management alone in patients with symptomatic intracranial atherosclerotic stenosis?

Angioplasty 45

Angioplasty Stenosis Article 45

American College of Cardiology

OCTOBER 28, 2024

The goal of the DCB-BIF trial was to assess the efficacy of drug-coated balloon (DCB) angioplasty of residual side branch stenosis in coronary bifurcation lesions treated with a provisional stenting strategy.

Angioplasty 56

Angioplasty Stents Stent Stenosis 56

Journal of Cardiothoracic Surgery

DECEMBER 18, 2024

This study aimed to analyze the safety and mid-term outcomes of a hybrid treatment method combining rotational atherectomy (RA) with drug-coated balloon (DCB) angioplasty in patients with femoropopliteal arter.

Angioplasty 52

Angioplasty Stents Stent Outcomes 52

HCPLive

APRIL 29, 2024

Abbott's Esprit BTK System was shown to significantly reduce risk of ischemic events in patients with PAD versus angioplasty over 1 year.

Peripheral Arterial Disease 111

Peripheral Arterial Disease Angioplasty Stents Stent 111

Med Page Today

OCTOBER 1, 2024

(MedPage Today) -- A look at the feasibility of coronary angiography and angioplasty procedures using the Meta Quest 3 virtual reality (VR) headset. European Heart Journal) FDA approved flurpiridaz F-18 (Flyrcado), a radiotracer for positron.

Angioplasty 101

Angioplasty 101

Stroke Journal

MARCH 23, 2025

The longstanding benefits of percutaneous angioplasty and stenting in coronary artery disease, where atherosclerosis is the overarching cause in nearly all cases, provided a compelling rationale for exploring similar interventions in intracranial atherosclerotic stenosis.

Angioplasty 40

Angioplasty Stenosis Coronary Artery Disease Stents 40

Medical Xpress - Cardiology

NOVEMBER 4, 2024

27 to 30 in Washington, D.C.

Angioplasty 40

Angioplasty Stents Stent 40

Heart BMJ

AUGUST 26, 2024

Balloon pulmonary angioplasty (BPA) is an effective treatment for CTEPH, but the efficacy of BPA in patients with CTEPH with low DLco remains unclear because BPA does not directly address microvascular damage.

Angioplasty 52

Angioplasty Pulmonary Exercise Hypertension 52

Journal of the American Heart Association

APRIL 16, 2025

This study aimed to clarify the influence of theRNF213p.Arg4810Lys variant on the response to balloon pulmonary angioplasty (BPA) in patients with CTEPH.MethodsWe retrospectively analyzed 93 patients with CTEPH who underwent BPA by analyzing theRNF213p.Arg4810Lys variant.

Angioplasty 45

Angioplasty Pulmonary Hypertension Risk Factors 45

DAIC

APRIL 11, 2024

The study, called IVUS-DCB, is the first randomized controlled trial to demonstrate the clinical benefits of using IVUS in angioplasty procedures for peripheral artery disease (PAD), a condition in which plaque builds up in arteries in the legs. Half were randomly assigned to receive IVUS plus angiography and half received angiography alone.

Peripheral Arterial Disease 116

Peripheral Arterial Disease Ultrasound Angioplasty Plaque 116

Circulation

MARCH 7, 2024

Balloon pulmonary angioplasty continues to gain traction as a treatment option for patients with chronic thromboembolic pulmonary disease with and without pulmonary hypertension. Not surprisingly, chronic thromboembolic pulmonary hypertension centers are rapidly initiating balloon pulmonary angioplasty programs.

Angioplasty 45

Angioplasty Pulmonary Hypertension Document 45

Stroke Journal

FEBRUARY 1, 2024

Introduction:Traditional endovascular treatment for acutely symptomatic intracranial atherosclerotic disease (ICAD) includes balloon angioplasty and stenting. Catheter mediated angioplasty (or “Dotter” angioplasty) has been previously described for extracranial carotid and peripheral arteries.

Angioplasty 40

Angioplasty Stenosis Stents Stent 40

HeartRhythm

APRIL 30, 2024

Intramural vein mapping via angioplasty wire can localize such foci, but RFA delivery via angioplasty wire is limited. The most common cause of radiofrequency ablation (RFA) failure is inability to reach intramural foci.

Angioplasty 40

Angioplasty Ablation 40

American College of Cardiology

SEPTEMBER 2, 2024

A strategy of drug-coated balloon (DCB) angioplasty with rescue stenting did not achieve noninferiority compared with intended drug-eluting stent (DES) deployment for patients with de novo, noncomplex coronary artery lesions, according to finding from the REC-CAGEFREE I trial presented at ESC Congress 2024 in London and simultaneously published in (..)

Angioplasty 40

Angioplasty Stents Stent Article 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Santa Clara, CA, USA) semi compliant balloon adapted from cardiovascular literature which showed a pre‐dilation angioplasty capability in coronary stenotic lesions.MethodsWe performed a retrospective review of prospectively maintained mechanical thrombectomy (MT) databases of 2 comprehensive stroke centers between November 2020, and May 2023.

Angioplasty 40

Angioplasty Stents Stent Stroke 40

American College of Cardiology

FEBRUARY 11, 2025

Calcified coronary lesions are associated with lower procedural success and higher complications with percutaneous coronary intervention. Previous study data have shown improved procedural success with routine use of atherectomy in these patients without meaningful differences in clinical outcomes.

Angioplasty 56

Angioplasty Outcomes Article 56

Becker's Hospital Review - Cardiology

NOVEMBER 7, 2024

A drug-eluting resorbable stent was found to be just as effective in treating infrapopliteal artery disease in patients at risk of limb amputation, according to a study published Oct. 25 in the New England Journal of Medicine.

Stents 52

Stents Stent Angioplasty Outcomes 52

Med Page Today

MAY 15, 2024

(MedPage Today) -- PARIS -- Antiplatelet de-escalation worked well following drug-coated balloon (DCB) placement for acute coronary syndrome (ACS), according to the first randomized trial on this subject. In REC-CAGEFREE II, the strategy of.

Angioplasty 52

Angioplasty 52

American College of Cardiology

JANUARY 6, 2025

The first successful percutaneous transluminal coronary angioplasty was performed by Andreas Gruentzig, MD, in September 1977.

Angioplasty 68

Angioplasty Article 68

Frontiers in Cardiovascular Medicine

JULY 24, 2024

This review delves into the current therapeutic strategies for CTEPH, including surgical pulmonary endarterectomy (PEA), balloon pulmonary angioplasty (BPA), and targeted pharmacological treatments such as PDE5 inhibitors, endothelin receptor antagonists, sGC stimulators, and prostanoids.

Pulmonary 98

Pulmonary Hypertension Angioplasty Pharmacology 98

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

We included articles reporting patients > 18 years old with symptomatic extracranial vertebral artery stenoses due to atherosclerosis treated with stenting (with or without angioplasty). During follow‐up, in‐stent stenosis >50% was observed in 12.8%, and retreatment with either re‐stenting or angioplasty was performed in 10.8%.

Angioplasty 40

Angioplasty Stents Stent Stenosis 40

American College of Cardiology

DECEMBER 21, 2023

The goal of the ORBITA-2 trial was to assess the efficacy of percutaneous coronary intervention (PCI) compared with a sham placebo procedure for angina relief among patients with stable angina who were not on background antianginal medication.

Angina 60

Angina Angioplasty Article 60

Stroke Journal

JANUARY 30, 2025

The objective of our study is to identify factors associated with SBIs following middle cerebral artery (MCA) stenting or balloon angioplasty.Methods:We retrospectively reviewed patients who underwent MCA stenting or balloon angioplasty, including those with symptomatic, atherosclerotic MCA stenosis of 50%.

Angioplasty 40

Angioplasty Stents Stent Stenosis 40

JAMA Cardiology

DECEMBER 22, 2024

This narrative review discusses drug-coated balloon angioplasty as an alternative to drug-eluting stent for percutaneous coronary intervention in patients with in-stent restenosis and de novo coronary artery disease.

Coronary Artery Disease 66

Coronary Artery Disease Angioplasty Stents Stent 66

American College of Cardiology

OCTOBER 29, 2024

The goal of the ECLIPSE trial was to evaluate orbital atherectomy prior to drug-eluting stent (DES) implantation compared with conventional percutaneous coronary intervention (PCI) without atherectomy among patients with calcified coronary lesions.

Angioplasty 53

Angioplasty Stents Stent Article 53

DAIC

MARCH 1, 2024

1,2 Serving as an alternative to traditional therapies such as balloon angioplasty, additional layers of stenting or radiation, the AGENT DCB is a paclitaxel-coated balloon catheter that transfers a therapeutic dose of drug to the vessel wall to help prevent ISR reoccurrence. vs. 28.7%; P=0.006).

Stents 105

Stents Stent Coronary Artery Disease Angioplasty 105

Stroke Journal

FEBRUARY 1, 2024

Background:In stroke patients undergoing EVT, angioplasty and stenting (A&S) has been described as a bailout technique when thrombectomy fails or intracranial stenosis is suspected. Stroke, Volume 55, Issue Suppl_1 , Page AWMP88-AWMP88, February 1, 2024.

Stents 40

Stents Stent Angioplasty Stenosis 40

DAIC

NOVEMBER 8, 2024

among 6 randomized controlled trials (RCTs) (172 patients), comparing favorably to published meta-analysis rates for uncoated balloon angioplasty (47.4% in 11 RCTs) were also similar or better than meta-analysis rates for balloon angioplasty or DCB, with variations based on study design and artery level.3-6

Stents 52

Stents Stent Angioplasty Peripheral Arterial Disease 52

Med Page Today

APRIL 30, 2024

(MedPage Today) -- For patients with peripheral artery disease (PAD) and chronic limb-threatening ischemia, drug-eluting stents and drug-coated balloons did not improve amputation-free survival compared with balloon angioplasty alone in the BASIL.

Peripheral Arterial Disease 64

Peripheral Arterial Disease Angioplasty Heart Disease Cancer 64

Med Page Today

MAY 19, 2024

(MedPage Today) -- PARIS -- Whether a person had chest pains resolved by angioplasty hinged on the nature, not the severity, of their presenting symptoms, an ORBITA-2 analysis showed. Investigators found two groups more likely to benefit from.

Chest Pain 59

Chest Pain Angina Angioplasty 59

The American Journal of Cardiology

JULY 18, 2024

Publication date: Available online 18 July 2024 Source: The American Journal of Cardiology Author(s): Safia Shaikh, Mohammad Hamza, Prakash Upreti, Mohammad Akkawi, Kripa Rajak, Mobeen Zaka Haider, Nomesh Kumar, Mustafa Turkmani, Fadi Kathawa, Salman Abdul Basit, Yasemin Bahar, Sadaf Fakhra, Yasar Sattar, M Chadi Alraies

Angioplasty 52

Angioplasty Stents Stent 52

Medical Xpress - Cardiology

SEPTEMBER 2, 2024

Novel drug-coated balloons (DCB) did not outshine standard treatment with second generation drug-eluting stents (DES) as they were expected to, in a surprise finding of the first randomized trial to compare clinical outcomes in previously untreated patients with non-complex disease undergoing percutaneous coronary intervention (PCI). 2 Sept.).

Stents 45

Stents Stent Angioplasty Outcomes 45